(Q35077109)

6 August 2017

1 reference

title

Cytokines and sickness behavior: implications for cancer care and control (English)

1 reference

6 August 2017

Andrew H Miller

1

1 reference

6 August 2017

1 February 2003

1 reference

Brain, Behavior, and Immunity

6 August 2017

1 reference

6 August 2017

17 Suppl 1

1 reference

6 August 2017

S132-4

1 reference

Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Cytokine-induced sickness behavior: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Sickness behavior as a new target for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Mood and cognitive disorders in cancer patients receiving cytokine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Paroxetine for the prevention of depression induced by high-dose interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Assessment and treatment of depression in the cancer patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Mind matters -- group therapy and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Glial activation: a driving force for pathological pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2802%2900080-6

7 January 2021

10.1016/S0889-1591(02)00080-6

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12615199